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Abstract
Objective
To evaluate sensitivity/specificity of the maximum relaxation rate (MRR) of inspiratory mus-
cles, amplitude of electromyographic activity of the sternocleidomastoid (SCM), scalene
(SCA), parasternal (2ndIS) and rectus abdominis (RA) muscles; lung function and respira-
tory muscle strength in subjects with Myotonic dystrophy type 1 (DM1) compared with
healthy subjects.
Design and methods
Quasi-experimental observational study with control group. MRR of inspiratory muscles,
lung function and amplitude of the electromyographic activity of SCM, SCA, 2ndIS and RA
muscles during maximum inspiratory pressure (PImax), maximum expiratory pressure
(PEmax) and sniff nasal inspiratory pressure (SNIP) tests were assessed in eighteen DM1
subjects and eleven healthy.
Results
MRR was lower in DM1 group compared to healthy (P = 0.001) and was considered sensitive
and specific to identify disease in DM1 and discard it in controls, as well as SNIP% (P = 0.0026),
PImax% (P = 0.0077) and PEmax% (P = 0.0002). Contraction time of SCM and SCA was higher
in DM1 compared to controls, respectively, during PImax (P = 0.023 and P = 0.017) and SNIP
(P = 0.015 and P = .0004). The DM1 group showed lower PImax (P = .0006), PEmax (P =
0.0002), SNIP (P = 0.0014), and higher electromyographic activity of the SCM (P = 0.002) and
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SCA (P = 0.004) at rest; of 2ndIS (P = 0.003) during PEmax and of SCM (P = 0.02) and SCA (P
= 0.03) during SNIP test.
Conclusions
MD1 subjects presented restrictive pattern, reduced respiratory muscle strength, muscular
electrical activity and MRR when compared to higher compared to controls. In addition, the
lower MRR found in MD1 subjects showed to be reliable to sensitivity and specificity in identi-
fying the delayed relaxation of respiratory muscles.
Introduction
Myotonic dystrophy type 1 (MD1), or Steinert’s disease, is the most common form of dystro-
phy in adolescents and adults, and the second most common neuromuscular disease [1–3].
The classic form of MD1 is characterized by weakness and atrophy in skeletal muscles, myoto-
nia, cardiac conduction abnormalities, cognitive impairment and myocardial changes. Addi-
tionally, the involvement of respiratory muscles is common with reduction of respiratory
muscles strength, especially expiratory muscles [4–6], resulting in death [4], specifically due to
respiratory insufficiency or pneumonia [7],[8].
The respiratory impairment in MD1, is rather complex because progressive muscle weak-
ness is associated to different degrees of central respiratory control abnormalities causing alve-
olar hypoventilation[9]. In fact, CO2 insensitivity occur in MD1 independently of lung
function impairment and respiratory muscle weakness [10]. In addition the participation of
myotonia in DM1 respiratory restriction is not fully clarified.
Myotonia is characterized by a delayed relaxation of skeletal muscles after an intense con-
traction and is one of the most important clinical features of MD1 [11]. The presence of myo-
tonia determines the appearance of symptoms such as muscle stiffness and cramps. Although
few studies have been published, there are indications of its presence in the respiratory mus-
cles. In 1954, Benaim & Worster-Drougth [12] showed, through electromyography, the pres-
ence of myotonia in the intercostal muscles, but not in diaphragm. In 1959, Kilburn et al. [13]
observed in two cases a delayed return of the diaphragm to its resting position. Smorto et al.
[14] found high amounts of high frequency electrical activity, considered myotonia, in MD1
patients. In another case study, Estenne et al. [15] were able to detect abnormal muscle relaxa-
tion and registry of myotonia of the diaphragm and abdominal muscle by performing electro-
myographic and nasal inspiratory pressure test (SNIP) studies in a patient with congenital
myotonia (Thompsen disease). However, due to the presence of abnormalities in relaxation of
the diaphragm, which was confirmed by variations in abdominal pressure, the presence of
myotonia was attributed to the abdominal muscles and not to the diaphragm. In contradiction,
Fitting et al. [16] using similar methodology, found no changes in the abdominal muscles, but
in the diaphragm. Finally, Rimmer et al. [17] in a study with 11 MD patients, found only two
patients with electrical activity consistent to the presence of myotonia, as measured by surface
electromyography (sEMG) of the scalene, parasternal and external abdominal oblique muscles.
Therefore, the presence of myotonia in the inspiratory muscles of patients with MD is doubt-
ful, since most of the studies involve few patients with MD and, in some cases, inadequate
techniques.
For some years, the maximum relaxation rate (MRR) of the inspiratory muscles has been
used as an indirect marker of fatigue and overload of the inspiratory muscles. A decreasing
Muscle relaxation rate in Myotonic dystrophy
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MRR of skeletal muscle means muscle overload and precedes the failure of power generation
[18, 19]. Considering the muscle relaxation as an active process that consumes energy that can
be affected by different conditions, including fatigue, muscle weakness and atrophy of muscle
fibers [20], a decreasing MRR during the sniff test could be useful for evaluating the presence
of inspiratory muscles overload, signs of myotonia, and fatigue [21–23]. Therefore, the objec-
tives of this study were to evaluate the MRR and electrical activity of the inspiratory muscles in
patients with MD1. We hypothesized that markers of myotonia could be found in this popula-
tion by analyzing different parameters describing the strength, the relaxation and the electrical
activity of respiratory muscles. More specifically, we have considered maximal inspiratory
pressure (PImax), maximal expiratory pressure (PEmax) and SNIP test as indexes of strength
and MRR and sEMG as indexes of muscle relaxation and contraction, respectively.
Methods
Subjects and study design
This is an observational, quasi-experimental study, with control group [24]. Subjects were
individuals diagnosed with MD1 recruited from a clinical follow-up with a neurologist at a
University Hospital from January 2015 to June 2016. All patients and healthy subjects were
assessed in a single day after receiving initial information and recommendations on the prepa-
ration for the assessments.
Inclusion criteria for the MD1 group were: patients aged between 18 and 65 years, properly
diagnosed and accompanied by a neurologist. Those who were smokers (or ex-smokers) or
presented obstructive respiratory disease, musculoskeletal comorbidities or impaired intellec-
tual ability (established by medical diagnosis) that would prevent the assessments, who failed
to perform tests for other reasons or quit from the study were excluded. The control group
included self-reported healthy subjects matched for gender and age. Individuals who were
smokers (or ex-smokers) or presented cardiac, respiratory or musculoskeletal comorbidities,
deviated septum, rhinitis or nasal obstruction, as well as those who failed to perform the tests
or gave up from participating of study were excluded. Additionally, healthy subjects should
not use any type of drug that could interfere with the test results, such as antihypertensive or
bronchodilator drugs. All subjects agreed to participate in the study by signing an informed
consent form, which was approved by the Ethics Committee of the Federal University of Rio
Grande do Norte/Brazil (protocol no: 752.322) according to the Declaration of Helsinki.
Clinical phenotype and muscle impairment MD1 classification
The MD1 patients were classified in relation to degree of muscle impairment and clinical phe-
notypes [25] by the neurologist according to the Muscle Impairment Rating Scale (MIRS) [26],
and the MD1-specific form according to age and onset and clinical symptoms. The MIRS is
structure in five degrees of impairment in relation to muscle involvement, progressing from
distal to proximal: grade 1, no muscular impairment; grade 2, minimal signs (myotonia and
digit flexors and craneal muscle wasting and weakness); grade 3, distal weakness (no proximal
weakness except isolated elbow extensor weakness); grade 4, mild to moderate proximal weak-
ness; grade 5, severe proximal weakness. The phenotype classification includes four categories:
1- congenital, 2- juvenile, 3- classic adult onset and 4- mild late-onset.
Lung function
Spirometry was performed through a KoKo DigiDoser1 spirometer (nSpire Health, Inc.
Longmont, USA) and considered complete when three acceptable curves were produced (with
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variation equal to or lower than 5% of the highest value). The technical procedure, the accep-
tance and reproducibility criteria as well as the standardization of equipment followed the
recommendations of the ATS/ERS [27]. The reference values used in this study had been pre-
viously published for the Brazilian population [28].
Respiratory muscle strength
Respiratory muscle strength was assessed from measurements of PImax, PEmax and SNIP by
a digital manometer (NEPEB-LabCare/UFMG, Belo Horizonte, Brazil), following the proce-
dures previously published by the Brazilian Society of Pneumology [29]. PImax was measured
from residual volume and PEmax from total lung capacity, using a nose clip. The highest value
obtained in a maximum of five tests (with variation equal to or lower than 10% of the highest
value) was used for each assessment. SNIP was obtained from functional residual capacity,
with the subject having one nasal cavity occluded by a plug coupled to a catheter connected to
a digital manometer, while maintaining the other nostril open[30]. Previously published refer-
ence values were used [31].
In order to identify respiratory muscle weakness, cutoff values were adopted and calculated
as the mean of the normal population, published previously, minus 1.96 multiplied by the stan-
dard deviation. The reference values of Neder et al. [31] were used for PImax and PEmax; and
the reference values of Araujo et al. [30] were used for SNIP. The cutoff values established for
men and women, respectively, were: 59.1 cmH2O and 70.4 cmH2O for PImax; 58.2 cmH2O
and 53.9 cmH2O for SNIP; 101.1 cmH2O and 69.2 cmH2O for PEmax.
Assessment of maximum relaxation rate of inspiratory muscles
MRR was derived from SNIP test and calculated using LabChart Reader 8.0 software (ADIn-
struments, New Zealand). The values were obtained as the first derivative of pressure-time
curve (dP/dT) over the first half of the relaxation curve by calculating the tangent at the stee-
pest part of the pressure curve. To exclude the effect of pressure oscillation amplitude on MRR
[21], dP/dT was normalized and expressed as percentage of the pressure drop in every 10 milli-
seconds (dP/dt) / Psniff100 (%10ms) [22]. The following criteria were established for choos-
ing the best SNIP value for calculation of MRR: (1) sniff maneuver performed from FRC; (2)
peak pressure maintained for less than 50 milliseconds; (3) total duration of the maneuver less
than 500 milliseconds; and (4) shape of SNIP curve showing soft peaked curves with upward
and downward movement [21],[22].
Surface electromyography
Capture and processing of myoelectric signals were performed using TeleMyo DTS Desk
Receiver1 (Noraxon, USA, Inc., Scottsdale, USA) electromyograph and 4 wireless Clinical
DTS (Noraxon, USA, Inc., USA) sensors with 16-bit resolution and common-mode rejection
ratio > 100 dB. The sampling frequency of the captured signals was 1500 Hz, with 500 Hz low
pass filter and signals pre-amplified 1000 times. The software used to capture and store the
myoelectric signals during PImax, PEmax and SNIP tests was MR 3.2 (Noraxon, USA, Inc.,
USA). Ag/AgCl bipolar surface electrodes were placed along the direction of the muscle fibers,
all in the right side of the body to avoid contamination by the cardiac electrical signals. The
skin of the volunteers was properly prepared in order to reduce impedance, favoring the cap-
ture of a signal with greater amplitude, with less interference and noise [32]. To capture
electromyographic signals, all recommended procedures were strictly followed [33].
Electrodes were placed over the parasternal muscle on the second intercostal space (2ndIS),
3 cm from the sternum; the sternocleidomastoid muscle (SCM), on the muscle belly, 5 cm
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from the mastoid process; the rectus abdominis (RA), 4 cm from the umbilical scar; and the
scalene muscle (SCA), on the muscle belly, 5 cm from the sternoclavicular joint and 2 cm
above that mark [34]. Electromyographic signals were analyzed using the RMS (root mean
square) and normalized from the average of three maximum voluntary isometric contractions
for SCM, SCA, RA [35]; and three SNIP and PImax tests for 2ndIS [36].
In order to quantify possible delayed muscle relaxation, the duration of electrical activity of
each muscle studied was measured and normalized by the duration of the different maneuvers
(SNIP, PImax and PEmax). The duration of each respiratory muscle contraction (i.e., the dif-
ference between onset and offset time during the maneuver) was automatically calculated by
analyzing the time course of pressure curves using the MR3.2 software (MyoMuscle Module,
Noraxon, USA).
Sample size and statistical analysis
Sample size was calculated through a pilot study with five MD1 subjects. The standard devia-
tion of the MRR variable was used for a hypothetical t test. Twelve subjects in each group were
required to achieve 80% power with P<0.05. Data normality were checked using Shapiro-
Wilk test . Parametric data were compared using the Unpaired t-test, while non-parametric
data were compared using the Mann-Whitney test. Significant levels were set at a 2-sided
P<0.05.
Receiver operating characteristic curves (ROC) were calculated using the MRR, SNIP%,
PImax%, PEmax% between MD1 patients and healthy subjects. ROC curve was calculated as
described previously by Hanley and McNeil [37]. Prism1 version 5 (GraphPad Software Inc,
USA) was used for data analysis and GPower version 3.1.9.2 (Franz Faul—Universita¨t Kiel,
Germany) for sample size, effect-size and power calculation.
Results
Sample size
Initially, 74 individuals were invited to participate in the study: 44 patients with MD1 and 30
healthy subjects. After exclusion criteria a total of 18 MD1 subjects and 11 healthy were
included in the study (Fig 1).
Considering the mean of each group and the difference between standard deviation of
MRR variable, a Cohen’s d = 3.89 (considered large) [38] was found. The power of the study
(1-ß), considered the effect size found, was 1.0.
Symptoms, severity and rate of progression of the disease
Demographic features of the patients are reported in Table 1. The mean age of the patients at
time of evaluation was 42.3 ± 11.3 and the mean time elapsed from diagnosis were 6.83 ± 5.98
years. In relation to phenotype, 88.8% (n = 16) were classified as a Classic form and 11.2%
(n = 2) as a Mild type. Regarding the classification on MIRS we found that 11,11% (n = 2) were
classified as MIRS 1, 55.5% (n = 10) classified as MIRS 2, 22.22% (n = 4) classified as MIRS 3
and 11,11% (n = 2) classified as MIRS 4.
Pulmonary function and respiratory muscle strength
The spirometric values for the MD1 group showed, on average, a moderate restrictive pattern
[39]. Regarding inspiratory muscle strength in the control group, 25% of women were below
the cutoff point, while in the MD1 group was 40%. Regarding male gender, 14.3% of control
group and 54.5% of MD1 group were below the cutoff point. In the SNIP test, all subjects were
Muscle relaxation rate in Myotonic dystrophy
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above the cutoff point in the control group, while in the MD1 group 63.6% of men and 80% of
women were below that point. In the PEmax assessment, where the biggest difference was
observed between the two groups, all healthy subjects met or were above the cutoff point for
muscle weakness. In the MD1 group, 90.9% of men and 80% of women did not reach that value.
For all maneuvers previously mentioned, the differences between the two groups were
statistically significant: in absolute values SNIP (P = 0.0014), PImax (P = 0.0006), PEmax
(P = 0.0002) and in percentage of predict values SNIP (P = 0.0015), PImax (P = 0.0016) and
PEmax (P<0.0001). Spirometric and respiratory muscle strength data are shown in Table 1
and Fig 2.
Electromyography of the respiratory muscles
In the MD1 group, 2 subjects were excluded due to the poor quality of the signal captured by
the sEMG. Obtained signals from the surface electromyography showed increased muscle
activity in MD1 subjects in most of the maneuvers carried out, with significant differences
found at rest for the SCM (P = 0.002) and SCA (P = 0.004). It was also found significant differ-
ence during the PEmax test for the 2ndIS (P = 0.003), and during SNIP for the SCM (P = 0.02)
and SCA (P = 0.03) (Fig 3).
Fig 1. Study flowchart.
https://doi.org/10.1371/journal.pone.0177318.g001
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Electrical activity time of respiratory muscles in patients with DM1 was significantly
increased compared to controls (Fig 4).
Maximum relaxation rate of inspiratory muscles
To assess MRR, four DM1 subjects were excluded from the analysis because their SNIP test did
not meet the criteria for proper data acquisition. The MRR was significant lower in MD1
group compared to control group (P = 0.001; 5.7±1.2 vs. 7.9±1.7, respectively) (Fig 2).
ROC analysis
The results, considering the Area Under the Curve, showed, for all variables, a good ability to
discriminate between those individuals with the disease and those without it. The thresholds of
sensitivity/specificity, confidential interval of area and p values are shown in Fig 5.
The area under the curve (AUC) above 0.80 associated with a P<0.05, for all the variables
(maneuvers), lead to the conclusion that these variables show a good ability to discriminate
between those individuals with the disease and those without it.
Discussion
The study results showed that the MRR is reduced in MD1 subjects compared to healthy. The
MRR of inspiratory muscles was considered sensitive to identify the presence of reduced MRR
in MD1 patients and specific to discard it in healthy individuals. According to the results of the
ROC curve analysis, which determined a cutoff point of 5.65; the electrical activity of the acces-
sory muscles of respiration (SCM, SCA and RA) was increased in MD1 compared to controls
(P = 0.004; P = 0.009; P = 0.045, respectively). In addition, lung function was also altered in
MD1 group as well as reduced respiratory muscle strength showing considered as muscle
weakness.
Table 1. Anthropometric data, lung function, respiratory muscle strength and maximum relaxation rate of inspiratory muscles.
Variable Control Group DM1 Group P value
Gender F/M 4/7 7/11 -
Age (years) 37.4 ± 10.7 42.3 ± 11.3 .2743
BMI (Kg/m2) 25.5 ± 4.2 24.9 ± 3.6 .7231
FVC (%pred.) 92.6 ± 11.9 72.1 ± 16.6 .0018
FEV1 (%pred.) 93.1 ± 10.9 70.2 ± 16.5 .0004
FEV1/FVC (%pred.) 101 ± 4.1 97.4 ± 5.6 .0781
PImax (cmH2O) 105 ± 29.1 62.6 ± 26.1 .0006
PImax% 99 (IQR: 75.3–115) 48 (IRQ: 37–57) .0016
PEmax (cmH2O) 114 (IQR: 101–145) 43.5 (IQR: 36.2–62.7) .0002
PEmax% 102 (IRQ: 89–132.6) 39.7 (IRQ: 28.5–60.5) < .001
SNIP (cmH2O) 72 (IQR: 63–89) 46 (IQR: 36,2–60,5) .0014
SNIP% 70.64 ± 19.6 46 ± 16.26 .0015
MRR%/10ms 7.9 ± 1.7 5.7 ± 1.2 .0010
Data presented as mean and standard deviation (parametric variables—Unpaired t test) and median and interquartile range (nonparametric variables—
Mann-Whitney test). BMI—Body Mass Index; Kg/m2—kilograms per square meter; FVC—forced vital capacity; % pred.- percentage of the value compared
to the predicted value; FEV1—forced expiratory volume in one second; PImax—maximum inspiratory pressure; cmH2O - centimeters of water; PEmax—
maximal expiratory pressure; IQR—interquartile range; SNIP—sniff nasal inspiratory pressure; MRR—maximum relaxation rate. The MRR analysis was
conducted with 14 patients.
https://doi.org/10.1371/journal.pone.0177318.t001
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The MRR of inspiratory muscles has been studied for about 25 years. This is an index of
fatigue and overload of inspiratory muscles, developed from sniff maneuvers obtained by mea-
suring esophageal or transdiaphragmatic pressure, which are invasive methods [19,20,22].
Subsequent studies [21,36] have observed a high relationship between the MRR obtained
through sniff maneuvers associated with esophageal pressure and with nasal pressure, provid-
ing a non-invasive measurement of that variable. Despite the technical characteristics of MRR
as a measure capable of identifying the delay in inspiratory muscle relaxation in MD1 and,
therefore, suitable for assessing the presence of myotonia, we have not found previous studies
of MRR obtained through nasal inspiratory pressure in MD1.
Fitting & Leuenberger [16] were the first authors to study MRR in a single case in 1989.
These authors evaluated the effects of procainamide, an anti-myotonic drug, in the diaphragm
through transdiaphragmatic pressure. Due to the type of study and the technique used, com-
parisons are inappropriate. Another study published by Jammes et al. [40], aimed to analyze
the electrical activity of the diaphragm and intercostal muscle during loaded inspiratory and
expiratory breathing. The authors suggest that the absence of relaxation in diaphragm muscle
Fig 2. Comparison between MRR (A), SNIP (B), PImax (C) and PEmax (D) for DM1 and control group. Data and cutoffs of respiratory muscle
weakness for PImax, PEmax and SNIP are presented in absolute values. The cutoff points established for male and female, respectively, were: 59.1
cmH2O and 70.4 cmH2O, for PImax; 58.2 cmH2O and 53.9 cmH2O, for SNIP; 101.1 cmH2O and 69.2 cmH2O for PEmax. All data showed parametric
distribution and were compared using Unpaired t test. Differences were considered significant when P<0.05.
https://doi.org/10.1371/journal.pone.0177318.g002
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during expedition may be related to the persistence of repetitive discharge due to a failure o
neural inhibitory circuits or to myotonia. More recently, Garcia-Rio et al [41] were the first to
assess noninvasively the MRR of inspiratory muscles using SNIP curve in 20 patients with dif-
ferent neuromuscular diseases (5 amyotrophic lateral sclerosis, 3 duchenne muscular dystro-
phy, 2 myotonic dystrophy, 7 myasthenia gravis, 2 congenital myopathy and brachial plexus
palsy) and 10 healthy subjects. These authors used a similar methodology to calculate MRR
and found a significantly lower MRR in the neuromuscular group compared to healthy
(7.21 ± 0.68 vs. 9.31 ± 1.22). Regarding our results, we also found a significantly lower MRR in
MD1 patients however; the study of Garcia-Rio et al. used a heterogeneous sample with several
different neuromuscular diseases.
Neuromuscular disorders, despite having some common physiopathological characteristics,
have varying degrees of severity and progression, which makes unsuitable grouping these dis-
eases for assessment of MRR and its subsequent comparison to a control group. It is important
to report that the MD1 is characterized by the presence of myotonia in the skeletal muscles and
possibly, in the inspiratory muscles, which could potentially affect the relaxation of these mus-
cles and reduce the MRR. Regarding the ROC curve, the high sensitivity and specificity found
Fig 3. Surface electromyography during the electrical activity of the muscles SCM, SCA, RA and 2ndIS at rest (A), SNIP (B), PImax (C) and PEmax
(D). Values were normalized and are shown in normalized data (% of RMS at rest) in SCM, SCA and RA. The normalized data from 2ndIS was done
considering the RMS of maximal values of SNIP and PImax maneuvers of each muscle, during the maneuvers. The sEMG measure at 2ndIS was
normalized by SNIP and PImax, both maximal measures of inspiratory muscles. All data presented non-parametric distribution and were compared
using the Mann-Whitney test. Differences were considered significant when P<0.05.
https://doi.org/10.1371/journal.pone.0177318.g003
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for MRR quantifies with high statistical value the overall capacity of the MRR to discriminate
the pattern of inspiratory muscle relaxation in MD1 compared with healthy subjects. Regard-
ing pulmonary function, our study confirmed previous results [42] as it was found the pres-
ence of moderate restrictive disorder in MD1. In relation to respiratory muscle strength,
Gillam et al [4] presented, in a series of 10 patients, values considered below the cutoff point
for muscle weakness of the expiratory muscles in 50% of subjects, with values less than 80
cmH2O for men and 60 cmH2O for women. Recently, similar results have been reported in the
literature, in which approximately 50% of patients presented expiratory muscle strength with
values below the cutoff point for expiratory muscle weakness [6]. These same authors also
showed PEmax, PImax and SNIP percentage of predicted values of about 64%, 70% and 80%,
respectively. Additionally, in a study analyzing respiratory muscle strength involving different
neuromuscular diseases, patients with MD1 have shown a reduction in respiratory muscle
strength and PEmax/PImax ratio below normal [5]. In the present study, changes in respira-
tory muscles strength were reinforced by the changes observed in the sEMG.
A major limitation of our study was the small sample size due to the limited time and fi-
nancial support. However, we may consider the high power and effect size found and the low
prevalence of the disease. Additionally, the results found in our study add new perspectives
regarding the MRR assessment (through the SNIP test) of subjects with MD1. We must inter-
pret the results of non-invasive MRR of inspiratory muscles in MD1 with caution, considering
that non-invasive MRR of inspiratory muscles in MD1 should be validated with golden stan-
dard methods as an invasive measurements of MRR during assessment of SNIP.
Conclusion
The study results may provide information that can contribute to a better understanding of
myotonic dystrophy type 1 and its impact on the respiratory system (either in its functional or
muscular aspect). These results may also contribute to the development of new evaluation
methods that may be routinely used in clinical practice. Moreover, we have brought new
approaches to the surface electromyography, which is still underused to assess respiratory
muscles and may be a complementary method for neuromuscular diseases researches.
Fig 4. Time of electrical activity of SCM, SCA, RA and 2ndIS muscles during SNIP (A) and PImax (B) assessment. Values are expressed in
seconds. All data showed parametric distribution and were compared using the unpaired t-test with Welch’s correction. Differences were considered
significant when P<0.05.
https://doi.org/10.1371/journal.pone.0177318.g004
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